fulvestrant has been researched along with Lupus Erythematosus, Systemic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdou, NI; Greenwell, C; Kimler, BF; Li, X; Rider, V | 1 |
| Dhaher, YY; Greenstein, BD; Hughes, GR; Khamashta, MA | 1 |
| Abdou, NI; Afsar, Z; Bassiri, H; Evans, M; Jones, S; Rider, V | 1 |
1 trial(s) available for fulvestrant and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Fulvestrant (Faslodex), an estrogen selective receptor downregulator, in therapy of women with systemic lupus erythematosus. clinical, serologic, bone density, and T cell activation marker studies: a double-blind placebo-controlled trial.
Topics: Adult; Antibodies, Antinuclear; Biomarkers; Bone Density; Calcineurin; CD40 Ligand; Disease Progression; Double-Blind Method; Down-Regulation; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Humans; Lupus Erythematosus, Systemic; Middle Aged; Quality of Life; Receptors, Estrogen; RNA, Messenger; Severity of Illness Index; T-Lymphocytes | 2008 |
2 other study(ies) available for fulvestrant and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Effects of oestradiol and the oestrogen antagonist Ici 182,780 on the delayed type hypersensitivity (DTH) index and on serum levels of IgM and IgG in ovariectomised Balb/C and MRL/Mp-Lpr/Lpr mice, a model of systemic lupus erythematosus (SLE).
Topics: Animals; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Hypersensitivity, Delayed; Immunoglobulin G; Immunoglobulin M; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Mice, Inbred MRL lpr; Ovariectomy; Receptors, Estradiol; Species Specificity | 2001 |
Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus.
Topics: Adult; CD3 Complex; CD40 Antigens; Cells, Cultured; Estradiol; Estrogen Antagonists; Estrogens; Female; Flow Cytometry; Fulvestrant; Humans; Ionomycin; Ionophores; Ligands; Lupus Erythematosus, Systemic; Middle Aged; Polymerase Chain Reaction; Receptors, Antigen, T-Cell; RNA, Messenger; T-Lymphocytes | 2001 |